| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.381 | 64.232 | 57.339 | 33.665 | 54.359 | 60.046 | 60.274 | 60.256 |
| Total Income - EUR | - | - | 10.381 | 64.233 | 57.339 | 33.665 | 54.359 | 60.625 | 61.194 | 60.713 |
| Total Expenses - EUR | - | - | 32 | 71.739 | 50.914 | 22.693 | 54.399 | 67.086 | 66.815 | 59.152 |
| Gross Profit/Loss - EUR | - | - | 10.349 | -7.506 | 6.424 | 10.971 | -40 | -6.462 | -5.621 | 1.561 |
| Net Profit/Loss - EUR | - | - | 10.037 | -9.432 | 4.704 | 9.961 | -1.671 | -8.263 | -6.224 | 1.313 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Viamedis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 1.384 | 460 | 0 |
| Current Assets | - | - | 10.393 | 1.667 | 5.594 | 13.493 | 11.425 | 2.852 | 1.390 | 1.096 |
| Inventories | - | - | 0 | 294 | 288 | 283 | 277 | 0 | 0 | 0 |
| Receivables | - | - | 2.189 | 9 | 200 | 3 | 0 | 0 | 1.025 | 709 |
| Cash | - | - | 8.203 | 1.364 | 5.106 | 13.207 | 11.148 | 2.852 | 365 | 387 |
| Shareholders Funds | - | - | 10.081 | 464 | 5.159 | 12.955 | 10.997 | 2.768 | -3.464 | -2.132 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 312 | 1.203 | 436 | 538 | 428 | 84 | 4.854 | 3.228 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 1.384 | 460 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8230 - 8230" | |||||||||
| CAEN Financial Year |
8230
|
|||||||||
Comments - Viamedis S.r.l.